Cargando…
Discontinuation of vascular therapeutics during the COVID-19 pandemic first wave in France
Autores principales: | Lanéelle, D., Dadon, M., Quere, I., Zuily, S., Emmerich, J., Sevestre, M.-A., Mahé, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816936/ https://www.ncbi.nlm.nih.gov/pubmed/33752851 http://dx.doi.org/10.1016/j.jdmv.2021.01.002 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on therapeutic management of rheumatoid arthritis in Brittany (France)
por: Queré, Baptiste, et al.
Publicado: (2021) -
Proposal of the French Society of Vascular Medicine for the prevention, diagnosis and treatment of venous thromboembolic disease in outpatients with COVID-19
por: Khider, L., et al.
Publicado: (2020) -
Comparison of the first and second waves of coronavirus disease in Toulouse, France
por: Jourdes, Aurelie, et al.
Publicado: (2022) -
Reflections and recommendations on the COVID-19 pandemic: Should hormone therapy be discontinued?
por: Cagnacci, A., et al.
Publicado: (2020) -
First Isolation of Rickettsia slovaca from a Patient, France
por: Cazorla, C., et al.
Publicado: (2003)